ARCHIVES

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 30, 2010

It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request

September 23, 1983

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

Limb-Sparing Surgery May Not Offer Better Quality of Life

August 28, 2009

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992